Miriam S Komaromy, MD
Medical Director, Grayken Center for Addiction
Existing Patients
Make an appointment by phone
617.414.5951
Make an appointment with MyChart
Book with MyChart
New Patients
If you are a new patient and need an appointment, please contact us at the phone number below.
Learn more about coming to BMC. 617.414.5951Refer a Patient
Refer a patient
Call for assistance with the referral process
617.414.5951
Featured on HealthCity
BMC Launches New Housing Initiative at 'Mass and Cass' with City of Boston
The low-threshold, transitional housing model aims to help people experiencing homelessness alongside addiction, mental health, and other concerns.
To Address 'Mass and Cass' Crisis, Transitional Housing Is Crucial
Low-barrier, temporary housing allows people with addiction to stabilize and prepare for transition into permanent housing.
Safe Consumption Sites Directly Meet the Needs of the BMC Community
Grayken Center for Addiction staff testified to the state on the need for safe consumption sites to address opioid overdose deaths.
Mandatory Reporting Law Is Harmful for Pregnant People with SUD
BMC experts testified in support of eliminating the requirement to report abuse and neglect for babies born with neonatal opioid withdrawal syndrome.
New Buprenorphine Prescribing Rules Won't Solve the Opioid Crisis
Miriam Komaromy, director of BMC's Grayken Center for Addiction cautions that the new rules don't go far enough in addressing opioid overdose deaths.
Lessons Learned from BMC's COVID-19 Unit for Homeless Patients
BMC created a medical unit to provide homeless, COVID-positive patients who were not sick enough to need hospitalization a location to recuperate.
Breaking Down the Changes to Prescribing Buprenorphine for OUD
Miriam Komaromy, MD, medical director for the Grayken Center for Addiction at BMC, reacts to the news of increased access to a key medication for OUD.
Nurse-Led Addiction Fellowship Begins at Boston Medical Center
Pioneering curriculum aims to strengthen inpatient nursing’s role in providing evidence-based care for patients with substance use disorder.
Building Reopens to Provide Continuum of Care for Homeless
In record time, local and state collaboration stands up respite care for stable COVID-positive people without a safe place to quarantine.
Preventing the Next Wave of the Opioid Crisis During COVID-19
Addiction expert Miriam Komaromy offers a frank look at the opioid epidemic and shares how efforts are underway to keep crucial care accessible.
ECHO Model Addresses Complex, High-Cost Patients’ Needs
Virtual sessions between primary care providers and specialty providers help reduce expensive emergency department and inpatient care utilization.
More About Me
Dr. Miriam Komaromy is a physician and Medical Director of Boston Medical Center’s Grayken Center for Addiction. She is board certified in Internal Medicine and Addiction Medicine. Komaromy’s work leading the Grayken Center is focused on enhancing all of BMC’s work on addiction, including clinical programs, education, research, and policy/advocacy, as well as elevating this work to influence the national dialog on addiction. Komaromy received her medical training at the University of California, San Francisco, and later served as a faculty member in the UCSF Department of Medicine. She was a Robert Wood Johnson Clinical Scholar at the UCSF/Stanford program, Prior to moving to Boston in 2019, she was Associate Director in the University of New Mexico’s ECHO Institute, developing and leading medical education programs that are focused on treatment of substance use disorders, for the past 13 years.
-
Education
University of California, San Francisco, CA (1989)
-
Location